Davis Polk is advising Roche Holding Ltd. in connection with the sale of an active pharmaceutical ingredients manufacturing facility in Florence, South Carolina, to Patheon N.V. Under the terms of the purchase agreement, Patheon will acquire the site for an immaterial sum, plus the cost of associated inventory and spare parts. Roche has also entered into a multi-year supply arrangement with Patheon.

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. Patheon is a global provider of pharmaceutical development and manufacturing services.

The Davis Polk corporate team includes partner Brian Wolfe and associates Cheryl Chan, Lillian deSouza Burr and Jeffrey Scharfstein. Counsel Betty Moy Huber and associate Michael Comstock are providing environmental advice. Partner Jean M. McLoughlin and associate Travis Triano are providing executive compensation advice. Counsel David R. Bauer is providing intellectual property and technology advice. Partner Rachel D. Kleinberg is providing tax advice. Members of the Davis Polk team are based in the New York and Northern California offices.

Copy link to share post